Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
MediciNova Inc
SWB:RMN
MediciNova Inc
SWB:RMN
Price:
3.218
EUR
-0.16%
Market Closed
Market Cap:
€159m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MediciNova Inc
SWB:RMN
|
US |
|
T
|
Toyo Tire Corp
SWB:TYR
|
JP |
|
Bonduelle SA
F:BDU
|
FR |
|
I
|
Idex Biometrics ASA
XMUN:I8X
|
NO |
|
C
|
Chilwa Minerals Ltd
F:SZ6
|
AU |
|
Shimadzu Corp
F:HDZ
|
JP |
|
W
|
Williams-Sonoma Inc
XMUN:WM1
|
US |
|
R
|
Russel Metals Inc
SWB:RMZ
|
CA |
Wall St Price Targets
RMN Price Forecast
Based on 6 analysts
Based on 6 analysts
+483% Upside
from
€3.218
today
MediciNova Inc (RMN)’s 12-month stock price forecast through September 2022 has a consensus target of €18.756, implying 483% upside. The forecast is based on price targets from 6 Wall Street analysts.
RMN Analyst Rating
No ratings yet
No ratings yet
MediciNova Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RMN's stock price target?
Price Target
18.756
EUR
18.756
EUR
According to Wall Street analysts, the average 1-year price target for RMN is 18.756 EUR with a low forecast of 13.929 EUR and a high forecast of 26.549 EUR.
What is the Revenue forecast for MediciNova Inc?
Projected CAGR
142%
142%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 8 years is 142%.
What is the Gross Profit forecast for MediciNova Inc?
Projected CAGR
227%
227%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -22%. The projected CAGR for the next 8 years is 227%.